Kalbe Farma Tbk Stock Performance
| PTKFY Stock | USD 21.05 0.00 0.00% |
The company secures a Beta (Market Risk) of 0.0, which conveys not very significant fluctuations relative to the market. the returns on MARKET and Kalbe Farma are completely uncorrelated.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Kalbe Farma Tbk has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong technical and fundamental indicators, Kalbe Farma is not utilizing all of its potentials. The newest stock price disturbance, may contribute to short-term losses for the investors. ...more
| Begin Period Cash Flow | 5.2 T | |
| Total Cashflows From Investing Activities | -1.1 T |
Kalbe |
Kalbe Farma Relative Risk vs. Return Landscape
If you would invest 2,105 in Kalbe Farma Tbk on January 30, 2024 and sell it today you would earn a total of 0.00 from holding Kalbe Farma Tbk or generate 0.0% return on investment over 90 days. Kalbe Farma Tbk is currently producing negative expected returns and takes up 0.0% volatility of returns over 90 trading days. Put another way, 0% of traded pink sheets are less volatile than Kalbe, and 99% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
Kalbe Farma Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Kalbe Farma's investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as Kalbe Farma Tbk, and traders can use it to determine the average amount a Kalbe Farma's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| PTKFY |
Based on monthly moving average Kalbe Farma is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Kalbe Farma by adding Kalbe Farma to a well-diversified portfolio.
Kalbe Farma Fundamentals Growth
Kalbe Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Kalbe Farma, and Kalbe Farma fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Kalbe Pink Sheet performance.
| Return On Equity | 0.17 | |||
| Return On Asset | 0.11 | |||
| Profit Margin | 0.12 % | |||
| Current Valuation | 5.89 B | |||
| Shares Outstanding | 231.28 M | |||
| Price To Earning | 32.31 X | |||
| Price To Book | 4.75 X | |||
| Price To Sales | 3.28 X | |||
| Revenue | 26.26 T | |||
| EBITDA | 4.54 T | |||
| Cash And Equivalents | 189.29 M | |||
| Cash Per Share | 0.81 X | |||
| Total Debt | 490.28 B | |||
| Debt To Equity | 0.03 % | |||
| Book Value Per Share | 4.20 X | |||
| Cash Flow From Operations | 2.83 T | |||
| Earnings Per Share | 0.96 X | |||
| Total Asset | 25.67 T | |||
About Kalbe Farma Performance
To evaluate Kalbe Farma Tbk Pink Sheet as a possible investment, you need to clearly understand its upside potential, downside risk, and overall future performance outlook. You may be satisfied when Kalbe Farma generates a 15% return over the last few months, but what if the market is generating 25% over the same period? In this case, it makes sense to compare Kalbe Pink Sheet's performance with different market indexes, such as the Dow or NASDAQ Composite. These indexes can act as benchmarks that will help you to understand Kalbe Farma Tbk market performance in a much more refined way. The Macroaxis performance score is an integer between 0 and 100 that represents Kalbe's market performance from a risk-adjusted return perspective. Generally speaking, the higher the score, the better is overall performance as compared to other investors. The score is normalized against the average investing universe (the best we can interpret from the data available). Within this methodology, scores of individual equity instruments will always be inferior to the scores of portfolios of equities as portfolios typically diversify a lot of unsystematic risks away. The formula to derive the Macroaxis score bases on multiple unequally-weighted factors. For more information, refer to our portfolio performance evaluation section.
Please also refer to our technical analysis and fundamental analysis pages.PT Kalbe Farma Tbk., together with its subsidiaries, develops, manufactures, and trades in pharmaceutical products in Indonesia. PT Kalbe Farma Tbk. was incorporated in 1966 and is headquartered in Jakarta, Indonesia. Pt Kalbe operates under Drug ManufacturersGeneral classification in the United States and is traded on OTC Exchange. It employs 12501 people.Things to note about Kalbe Farma Tbk performance evaluation
Checking the ongoing alerts about Kalbe Farma for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Kalbe Farma Tbk help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Kalbe Farma Tbk generated a negative expected return over the last 90 days |
- Analyzing Kalbe Farma's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Kalbe Farma's stock is overvalued or undervalued compared to its peers.
- Examining Kalbe Farma's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Kalbe Farma's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Kalbe Farma's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Kalbe Farma's pink sheet. These opinions can provide insight into Kalbe Farma's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Kalbe Farma Tbk. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in census. Note that the Kalbe Farma Tbk information on this page should be used as a complementary analysis to other Kalbe Farma's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.
Complementary Tools for Kalbe Pink Sheet analysis
When running Kalbe Farma's price analysis, check to measure Kalbe Farma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Kalbe Farma is operating at the current time. Most of Kalbe Farma's value examination focuses on studying past and present price action to predict the probability of Kalbe Farma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Kalbe Farma's price. Additionally, you may evaluate how the addition of Kalbe Farma to your portfolios can decrease your overall portfolio volatility.
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets |